Earnings · China A-shares
Zhuhai Trinomab Pharmaceutical Co., Ltd. Class A (688806) earnings
Zhuhai Trinomab Pharmaceutical Co., Ltd. Class A published its Q3 report on 2026-10-28: net profit +33.29% year on year. Wave Radar's earnings-quality score is 59 of 100 (Questionable). The stock moved -1.66% in the 3 trading days after the report.
- Report
- Q3 report
- Published
- 2026-10-28
- Period end
- 2026-09-30
- Net profit YoY
- +33.29%
- Result
- Bad / loss
- Quality score
- 59
- Quality
- Questionable
Stock move after the report
Trading days from the first tradeable session; dividend-adjusted. "vs index" is the excess return over CSI 300 for A-shares.
| After | Return | vs index |
|---|---|---|
| 1 day | -3.69% | — |
| 3 days | -1.66% | — |
| 7 days | +2.97% | — |
| 14 days | -7.55% | — |
Report history
Over the last 8 reports, net profit grew year on year in 3 of them. The stock rose in the 3 trading days after 1 of 2 reports (average -0.74%).
| Report | Published | Net profit | Profit YoY | Excl. one-offs YoY | Revenue YoY | EPS | ROE | 3 days after | 30 days after | 30d vs index |
|---|---|---|---|---|---|---|---|---|---|---|
| 2026 Q3 report | 2026-10-29 | -¥302.45M | +33.29% | — | +408.10% | -0.74 | -131.58% | -1.66% | — | — |
| 2026 interim report | 2026-08-26 | -¥199.35M | +31.29% | +32.56% | +623.41% | -0.51 | -407.07% | +0.17% | -5.02% | +1.97% |
| 2026 Q1 report | 2026-05-22 | -¥96.38M | +45.46% | +45.63% | +14623.36% | -0.25 | -161.38% | — | — | — |
| 2025 interim report | 2026-05-22 | -¥290.13M | — | — | — | — | — | — | — | — |
| 2025 annual report | 2026-03-11 | -¥601.32M | -16.81% | -17.78% | +240.23% | -1.56 | -195.86% | — | — | — |
| 2025 Q1 report | 2025-07-31 | -¥176.72M | — | — | — | -0.48 | -58.65% | — | — | — |
| 2024 annual report | 2025-07-31 | -¥514.77M | -15.30% | -13.41% | — | -1.42 | -102.24% | — | — | — |
| 2023 annual report | 2025-07-31 | -¥446.46M | -4.15% | -18.60% | -100.00% | -1.42 | -51.11% | — | — | — |
The last 8 reports. Net profit is attributable to shareholders and year-to-date (a Q3 report covers the first nine months). Moves count trading days from the first tradeable session after publication; "30d vs index" is the excess return over CSI 300.
How to read this
Results are grouped by reported profit growth (great, good, neutral, bad or a loss). For China A-shares the quality score starts at 100 and loses points for gaps a reader can check: operating cash falling short of profit, receivables or inventory outrunning revenue, profit that rests on one-off items or subsidies, heavy goodwill and a qualified audit opinion.
Figures are generated automatically from Wave Radar's published market data and refresh after each market close.